Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) has a beta value of 0.35 and has seen 111.84 million shares traded in the last trading session. The company, currently
During the recent session, Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)’s traded shares were 81.64 million, with the beta value of the company hitting 0.35. At the last
Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)’s traded shares stood at 0.35 million during the last session, with the company’s beta value hitting 0.36. At the close of
In last trading session, Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) saw 0.38 million shares changing hands with its beta currently measuring 0.38. Company’s recent per share price
Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)’s traded shares stood at 1.07 million during the last session, with the company’s beta value hitting 0.35. At the close of
In the last trading session, 1.63 million Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) shares changed hands as the company’s beta touched 0.37. With the company’s per share
In last trading session, Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) saw 0.26 million shares changing hands with its beta currently measuring 0.37. Company’s recent per share price
Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)’s traded shares stood at 12.62 million during the last session, with the company’s beta value hitting 0.40. At the close of
In the last trading session, 2.67 million Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) shares changed hands as the company’s beta touched 0.41. With the company’s per share
In recent trading session, Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) saw 2.05 million shares changing hands at last check today with its beta currently measuring 0.42. Company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
